ALZN: Alzamend Neuro, Inc. Company Short-Term Debt
This chart of the current share price for Alzamend Neuro, Inc. (ALZN) shows a value of 0.00. Alzamend Neuro, Inc. (ALZN) is competing for leadership in developing comprehensive dementia treatments, leveraging patent protection to maintain its market capitalization. ESG principles have been integrated into biosafety controls and trial ethics. The development strategy relies on immunotherapy and new forms of lithium for psychiatric therapy.
Comprehensive metric breakdowns and analytics for Alzamend Neuro Inc. (ALZN)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Equity Ratio Alzamend Neuro, Inc.|ALZN - Long-Term Liabilities to Equity|Short-Term Debt to Capital Alzamend|ALZN - Company Aggregate Debts|Debt to Book Capitalization Ratio Alzamend Neuro, Inc.|ALZN - Company Long-Term Liabilities|Company Short-Term Debts Alzamend Neuro|Quick Liquidity alzamend.com
- net income and valuation multiples indicators:
Analysis of all company metrics:ALZN - alzamend.com
To assess long-term risks, an investor analyzes the company's short-term loans and credits, which aggregate all liabilities maturing within one year to determine business liquidity. The stability of this metric confirms the operational discipline of Alzamend Neuro, Inc. management, allowing the team to focus on clinical trials for its neurological portfolio without the need for emergency debt financing.
Competitor analysis
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts xenon-pharma.com|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|Company Short-Term Debt SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc - Company Current Liabilities|DNLI (Denali Corp) - Current Liabilities|Harmony Biosciences - Company Short-Term Debts|BHVN - Company Short-Term Debts|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|Company Current Liabilities Trevi Therapeutics Inc|PRAX (Praxis Medicines) - Company Short-Term Debts|Short-Term Debt Anavex Life Sciences Corp AVXL|Company Short-Term Debt CeriBell, Inc. (CBLL)|Prothena Corporation plc - Company Short-Term Indebtedness|Company Short-Term Debts ALEC (Alector)|ANNX: Company Short-Term Indebtedness|OMER: Company Current Liabilities|Company Short-Term Loans and Borrowings NGNE (Neurogene Therapeutics)|AC Immune (ACIU) - Company Short-Term Debt|Company Short-Term Indebtedness VYGR|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|Short-Term Debt Scilex Holding SCLX|Company Current Liabilities TVGN (Tevogen Bio Holdings, Inc.)|Company Short-Term Debts alphacognition.com (ACOG)|Company Short-Term Debt Cognition Therapeutics, Inc. CGTX|Company Short-Term Loans and Borrowings IKT|SAVA - Company Short-Term Debt|Short-Term Debt Assertio Holdings, Inc.|COYA (coyatherapeutics.com) - Company Current Liabilities|Vistagen - Company Short-Term Loans and Borrowings|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|acumenpharm.com (ABOS) - Short-Term Debt Volume|Company Short-Term Debt CervoMed (CRVO)|alteritytherapeutics.com - Company Short-Term Indebtedness|Company Short-Term Debts CLNN (Clene)|PEPG - Company Current Liabilities|JUNS: Company Current Liabilities|Short-Term Debt Volume relmada.com RLMD|ANVS: Company Short-Term Debts|Grace Therapeutics (GRCE) - Company Short-Term Debts|Company Short-Term Debt Firefly Neuroscience Inc|Company Short-Term Debt KLTO|Company Current Liabilities NRSN (NeuroSense Therapeutics)|RVPH: Current Liabilities|Company Short-Term Debt MetaVia MTVA|NRXS: Company Short-Term Indebtedness|HSDT - Company Short-Term Debt|PASG (Passage Bio, Inc.) - Company Short-Term Indebtedness|NEUP: Company Short-Term Debts|Short-Term Debt minervaneurosciences.com (NERV)|Company Current Liabilities ATHA|Company Short-Term Debts Addex Therapeutics Ltd.|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|PTIX (protagenic.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|Cortigent Inc (CRGT) - Short-Term Debt|Avenue Therapeutics, Inc. - Company Short-Term Debts|BCLI - Company Short-Term Debts|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|CHRO (Chromocell) - Company Short-Term Debt|Company Current Liabilities ELYM|Intra-Cellular - Current Liabilities|Company Short-Term Debts LBPH|Company Short-Term Debts Marinus Pharmaceuticals Inc (MRNS)|Company Short-Term Debt NKGen NKGN|NRBO - Company Current Liabilities|Sage Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt synaptogen.com|Trevena (TRVN) - Company Short-Term Debt|Company Short-Term Indebtedness VIGL|WENA (Anew Medical, Inc.) - Company Short-Term Debts|Company Short-Term Indebtedness CERE (Cerevel Corp)